• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study.

作者信息

Sessarego M, Defferrari R, Dejana A M, Rebuttato A M, Fugazza G, Salvidio E, Ajmar F

机构信息

Cattedra di Clinica Medica R, University of Genoa, Italy.

出版信息

Cancer Genet Cytogenet. 1989 Nov;43(1):57-65. doi: 10.1016/0165-4608(89)90127-1.

DOI:10.1016/0165-4608(89)90127-1
PMID:2790773
Abstract

Between 1979 and 1988, 86 patients with clinical and laboratory findings consistent with essential thrombocythemia (ET) were karyotyped at diagnosis. Four patients showed a Philadelphia chromosome and underwent myeloid blastic crisis 2.5-4.5 years later, strongly suggesting a diagnosis of chronic myeloid leukemia. A partial deletion of 13q was seen in another case evolving to leukemia a few months later. Five cases, with normal karyotypes at diagnosis, developed acute transformation after more than 5 years of chronic phase. Four of them showed unusual clonal karyotype abnormalities involving different chromosomal regions. The numerical abnormalities found were trisomy 22 in one case, and trisomy 8 and 19 in another, while structural changes included partial deletion of 5p, partial deletion of 6q, pericentric inversion of chromosome 12, and partial deletion of 20q. These abnormalities have not been previously reported in ET. This investigation confirms the absence of a specific cytogenetic marker for ET, and the infrequent transformation to acute leukemia, often with chromosomal clonal disorders.

摘要

相似文献

1
Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study.
Cancer Genet Cytogenet. 1989 Nov;43(1):57-65. doi: 10.1016/0165-4608(89)90127-1.
2
Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
Eur J Haematol. 2002 Feb;68(2):112-6. doi: 10.1034/j.1600-0609.2002.01601.x.
3
Cytogenetic findings in untreated patients with essential thrombocythemia.未经治疗的原发性血小板增多症患者的细胞遗传学发现。
In Vivo. 2006 May-Jun;20(3):381-4.
4
Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.原发性血小板增多症的细胞遗传学异常:患病率及预后意义
Eur J Haematol. 2009 Jul;83(1):17-21. doi: 10.1111/j.1600-0609.2009.01246.x. Epub 2009 Feb 19.
5
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.原发性血小板增多症初诊时和转化后的细胞遗传学异常。
Int J Hematol. 2009 Nov;90(4):522-525. doi: 10.1007/s12185-009-0411-5. Epub 2009 Aug 29.
6
Chromosome 11 rearrangement at band 11q21 in a patient with essential thrombocythemia.
Cancer Genet Cytogenet. 1992 Jan;58(1):105-7. doi: 10.1016/0165-4608(92)90145-x.
7
Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.
Leuk Lymphoma. 1993 Mar;9(4-5):423-6. doi: 10.3109/10428199309148545.
8
Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet. 1988 Jun;32(2):157-68. doi: 10.1016/0165-4608(88)90278-6.
9
Unusual chromosome aberration, t(13;14)(q32;q32.3), in a case of essential thrombocythemia with extreme thrombocytosis.
Cancer Genet Cytogenet. 1996 Oct 1;91(1):68-70. doi: 10.1016/s0165-4608(96)00153-7.
10
De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.新发的der(1;7)(q10;p10)与原发性血小板增多症的白血病转化及不良预后相关。
Leuk Res. 2005 Nov;29(11):1247-52. doi: 10.1016/j.leukres.2005.03.011. Epub 2005 Apr 14.

引用本文的文献

1
Uncommon phenotypes of -positive chronic myelogenous leukemia.阳性慢性髓性白血病的罕见表型。
Haematologica. 2025 Sep 1;110(9):1912-1920. doi: 10.3324/haematol.2025.287792. Epub 2025 May 15.
2
The Prognostic Role of Cytogenetics Analysis in Philadelphia Negative Myeloproliferative Neoplasms.费城阴性骨髓增殖性肿瘤中细胞遗传学分析的预后作用。
Medicina (Kaunas). 2021 Aug 9;57(8):813. doi: 10.3390/medicina57080813.
3
Acute promyelocytic leukemia co-existing with JAK2 V617F positive myeloproliferative neoplasm: a case report.
急性早幼粒细胞白血病合并JAK2 V617F阳性骨髓增殖性肿瘤:一例报告
Stem Cell Investig. 2016 Mar 24;3:8. doi: 10.21037/sci.2016.03.02. eCollection 2016.
4
Blast transformation and fibrotic progression in polycythemia vera and essential thrombocythemia: a literature review of incidence and risk factors.真性红细胞增多症和原发性血小板增多症中的原始细胞转化和纤维化进展:发病率及危险因素的文献综述
Blood Cancer J. 2015 Nov 13;5(11):e366. doi: 10.1038/bcj.2015.95.
5
Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome.伴有JAK2 V617F突变和严重分化综合征的急性早幼粒细胞白血病
Leuk Res Rep. 2014 Dec 25;4(1):8-11. doi: 10.1016/j.lrr.2014.12.003. eCollection 2015.
6
Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.原发性血小板增多症初诊时和转化后的细胞遗传学异常。
Int J Hematol. 2009 Nov;90(4):522-525. doi: 10.1007/s12185-009-0411-5. Epub 2009 Aug 29.
7
The diagnosis of BCR/ABL-negative chronic myeloproliferative diseases (CMPD): a comprehensive approach based on morphology, cytogenetics, and molecular markers.BCR/ABL 阴性慢性骨髓增殖性疾病(CMPD)的诊断:一种基于形态学、细胞遗传学和分子标志物的综合方法。
Ann Hematol. 2008 Jan;87(1):1-10. doi: 10.1007/s00277-007-0403-6. Epub 2007 Oct 16.
8
Leukemogenic risk of hydroxyurea therapy as a single agent in polycythemia vera and essential thrombocythemia: N- and K-ras mutations and microsatellite instability in chromosomes 5 and 7 in 69 patients.羟基脲单药治疗真性红细胞增多症和原发性血小板增多症的致白血病风险:69例患者的N-和K-ras突变以及5号和7号染色体上的微卫星不稳定性
Int J Hematol. 2002 May;75(4):394-400. doi: 10.1007/BF02982131.
9
Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.家族性原发性血小板增多症:一个家族中11例患者的临床特征
Ann Hematol. 1994 Mar;68(3):153-8. doi: 10.1007/BF01727421.